<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>LVADs can also be lifesaving by maintaining hemodynamics during <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Continuous-flow LVADs have become the preferred LVAD technology </plain></SENT>
<SENT sid="3" pm="."><plain>As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> for over 12 hours when the internal defibrillator was unable to terminate the <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> </plain></SENT>
</text></document>